Stay updated on Adjuvant Nivolumab for Stage II Melanoma Clinical Trial

Sign up to get notified when there's something new on the Adjuvant Nivolumab for Stage II Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adjuvant Nivolumab for Stage II Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    6%
    Check dated 2025-02-10T09:19:59.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T04:55:25.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.0 to v2.14.1.
    Difference
    0.3%
    Check dated 2025-01-19T19:26:02.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in its functionality.
    Difference
    1.0%
    Check dated 2025-01-12T16:05:20.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T12:04:10.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The website has been updated from version v2.12.2 to v2.13.2, indicating a new release with potential improvements or features.
    Difference
    0.3%
    Check dated 2024-12-07T09:58:07.000Z thumbnail image

Stay in the know with updates to Adjuvant Nivolumab for Stage II Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adjuvant Nivolumab for Stage II Melanoma Clinical Trial page.